Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Orasure Technologies Inc's Business Segments
Orasure Technologies Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 31
Regions Reported
3
Revenue Share by Region -
- Africa22.1%
- Other Foreign Countries6.1%
- Europe5.7%
Revenue by Geographic Region -
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Africa | $ 7 | 22.1% |
| Other Foreign Countries | $ 2 | 6.1% |
| Europe | $ 2 | 5.7% |
Revenue by Product & Service Category -
- Product and Services97%
- HIV46.2%
- Molecular Products32.2%
- HCV11.1%
- Other Product and Services Revenues7.5%
- Other Revenues3%
- C O V I D190%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product and Services | $ 30 | 97% |
| HIV | $ 14 | 46.2% |
| Molecular Products | $ 10 | 32.2% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
4 more categories available
Sign in to unlock the full Orasure Technologies Inc dataset.
Description of Orasure Technologies Inc
Orasure Technologies Inc. is a public health diagnostic company that specializes in the development, manufacture, and distribution of oral fluid collection devices, diagnostic kits, and platform technologies. The company, which is headquartered in Bethlehem, Pennsylvania, was founded in 2000, and it primarily focuses on developing innovative medical solutions for HIV, hepatitis C, and other infectious diseases.
Orasure Technologies has developed a range of products that are marketed in more than 100 countries worldwide. Its flagship product is the OraQuick HIV, which is the first FDA-approved and CLIA waived rapid oral fluid test for HIV-1 and HIV-2. OraQuick is very easy to use, and it provides accurate results within 20 minutes, making it an important tool for public health screening programs.
In addition to OraQuick, Orasure Technologies has developed a portfolio of other health diagnostic products. These include OraSure, an oral specimen collection device used for testing hepatitis C; Intercept, a collection device used for oral fluid drug screening; and GenoSure PRIME, a genetic sequencing test used for HIV viral load monitoring.
One of the significant achievements of Orasure Technologies is its collaboration with the Centers for Disease Control and Prevention (CDC) to develop the first at-home HIV testing kit named "OraQuick In-Home HIV Test." The kit is marketed directly to the general public and provides an accessible home testing option, helping people control their HIV status and make informed decisions about their health.
Orasure Technologies has been recognized for its innovative technologies and outstanding business practices. It has been awarded numerous patents for its products and has been listed among the top 25 innovative companies by the Technology Fast 500 list in 2015.
In summary, Orasure Technologies Inc is a global industry leader in the public health diagnostic field, with products that are making a tremendous impact on combating the spread of infectious diseases such as HIV and hepatitis. The company has demonstrated a commitment to innovation and its corporate values of reliability, innovation, and excellence in serving its customers.
Orasure Technologies has developed a range of products that are marketed in more than 100 countries worldwide. Its flagship product is the OraQuick HIV, which is the first FDA-approved and CLIA waived rapid oral fluid test for HIV-1 and HIV-2. OraQuick is very easy to use, and it provides accurate results within 20 minutes, making it an important tool for public health screening programs.
In addition to OraQuick, Orasure Technologies has developed a portfolio of other health diagnostic products. These include OraSure, an oral specimen collection device used for testing hepatitis C; Intercept, a collection device used for oral fluid drug screening; and GenoSure PRIME, a genetic sequencing test used for HIV viral load monitoring.
One of the significant achievements of Orasure Technologies is its collaboration with the Centers for Disease Control and Prevention (CDC) to develop the first at-home HIV testing kit named "OraQuick In-Home HIV Test." The kit is marketed directly to the general public and provides an accessible home testing option, helping people control their HIV status and make informed decisions about their health.
Orasure Technologies has been recognized for its innovative technologies and outstanding business practices. It has been awarded numerous patents for its products and has been listed among the top 25 innovative companies by the Technology Fast 500 list in 2015.
In summary, Orasure Technologies Inc is a global industry leader in the public health diagnostic field, with products that are making a tremendous impact on combating the spread of infectious diseases such as HIV and hepatitis. The company has demonstrated a commitment to innovation and its corporate values of reliability, innovation, and excellence in serving its customers.
Orasure Technologies Inc. is a prominent provider of innovative solutions in the fields of infectious disease testing and genomics. The company operates across two primary segments: Infectious Disease Testing Products and Molecular Collection and Genomics Products. Each segment offers a comprehensive portfolio of products and services designed to enhance diagnostic capabilities and support clinical research.
Segments
1. Infectious Disease Testing Products
- This segment focuses on rapid diagnostic testing for various infectious diseases, primarily targeting viruses that significantly impact public health, such as HIV, Hepatitis C and B, and Zika virus. The segment also emphasizes the importance of sample collection and stabilization, providing laboratory instruments and supplies that enable effective testing in clinical environments.
2. Molecular Collection and Genomics Products
- The molecular segment is dedicated to collecting and analyzing genetic material, offering products and services for DNA and RNA collection, gene expression analysis, and genotyping. This segment also includes services aimed at supporting genetic testing, thereby contributing to advancements in personalized medicine and clinical research.
Products and Services
Infectious Disease Testing Products
1. OraQuick HIV-1/2
- A rapid, easy-to-use test that detects antibodies for HIV-1 and HIV-2. Results are available in just 20 minutes, significantly improving access to timely testing. The test is offered in two formats:
- Oral fluid, which is easy to use and non-invasive, and
- Fingerstick blood, which allows for traditional blood-based testing.
2. OraQuick HCV
- This rapid test detects antibodies to Hepatitis C virus (HCV) and delivers results in 20 minutes. Similar to the HIV test, it is available in oral fluid and fingerstick blood formats, allowing for flexible implementation in various testing environments.
3. OraSure Oral Specimen Collection Device
- This device is specifically designed to collect and stabilize oral fluid specimens for a range of infectious diseases, including HIV and Hepatitis B and C. The device enables efficient transportation of samples while preserving the integrity of the collected specimens.
4. Intercepte Blood System for Pathogens
- Utilizing advanced proprietary technology, this system is designed to inactivate a wide array of pathogens in donated blood and blood components. Its primary objective is to enhance blood safety by significantly reducing the risk of transfusion-transmitted infections.
Molecular Collection and Genomics Products
1. Genoteke DNA/RNA Collection Devices
- This product facilitates the collection, stabilization, and concentration of DNA and RNA from diverse sample types, including saliva, urine, and blood. The devices ensure that genetic material is preserved for subsequent analysis, essential for research and clinical purposes.
2. QIAGEN Reagents
- Orasure offers an array of reagents and consumables specifically formulated for genomic analysis. This includes products for genomic DNA and RNA isolation and purification, PCR amplification, and gene expression analysis, providing comprehensive solutions for genetic research.
3. Microarray Analysis
- The company provides a service that encompasses the analysis of genetic variations and gene expression profiles using state-of-the-art microarray technology. This service is vital for researchers looking to identify genomic differences related to diseases and other conditions.
4. Support for Genetic Testing
- An integral part of this segment, Orasure offers comprehensive services to support genetic testing initiatives. This includes training, consulting, and clinical trial support, ensuring that healthcare providers and researchers can effectively implement genetic testing in their practices.
Summary
Orasure Technologies Inc. delivers an extensive range of innovative products and services aimed at improving the quality and accessibility of infectious disease diagnostics and genomic analysis. With a focus on rapid testing, effective sample collection, and meticulous genomic research support, Orasure remains a key player in advancing healthcare technologies for better patient outcomes. Their products are strategically developed for use in clinical settings, research laboratories, and various healthcare facilities, ensuring they meet the evolving needs of the healthcare community.
Segments
1. Infectious Disease Testing Products
- This segment focuses on rapid diagnostic testing for various infectious diseases, primarily targeting viruses that significantly impact public health, such as HIV, Hepatitis C and B, and Zika virus. The segment also emphasizes the importance of sample collection and stabilization, providing laboratory instruments and supplies that enable effective testing in clinical environments.
2. Molecular Collection and Genomics Products
- The molecular segment is dedicated to collecting and analyzing genetic material, offering products and services for DNA and RNA collection, gene expression analysis, and genotyping. This segment also includes services aimed at supporting genetic testing, thereby contributing to advancements in personalized medicine and clinical research.
Products and Services
Infectious Disease Testing Products
1. OraQuick HIV-1/2
- A rapid, easy-to-use test that detects antibodies for HIV-1 and HIV-2. Results are available in just 20 minutes, significantly improving access to timely testing. The test is offered in two formats:
- Oral fluid, which is easy to use and non-invasive, and
- Fingerstick blood, which allows for traditional blood-based testing.
2. OraQuick HCV
- This rapid test detects antibodies to Hepatitis C virus (HCV) and delivers results in 20 minutes. Similar to the HIV test, it is available in oral fluid and fingerstick blood formats, allowing for flexible implementation in various testing environments.
3. OraSure Oral Specimen Collection Device
- This device is specifically designed to collect and stabilize oral fluid specimens for a range of infectious diseases, including HIV and Hepatitis B and C. The device enables efficient transportation of samples while preserving the integrity of the collected specimens.
4. Intercepte Blood System for Pathogens
- Utilizing advanced proprietary technology, this system is designed to inactivate a wide array of pathogens in donated blood and blood components. Its primary objective is to enhance blood safety by significantly reducing the risk of transfusion-transmitted infections.
Molecular Collection and Genomics Products
1. Genoteke DNA/RNA Collection Devices
- This product facilitates the collection, stabilization, and concentration of DNA and RNA from diverse sample types, including saliva, urine, and blood. The devices ensure that genetic material is preserved for subsequent analysis, essential for research and clinical purposes.
2. QIAGEN Reagents
- Orasure offers an array of reagents and consumables specifically formulated for genomic analysis. This includes products for genomic DNA and RNA isolation and purification, PCR amplification, and gene expression analysis, providing comprehensive solutions for genetic research.
3. Microarray Analysis
- The company provides a service that encompasses the analysis of genetic variations and gene expression profiles using state-of-the-art microarray technology. This service is vital for researchers looking to identify genomic differences related to diseases and other conditions.
4. Support for Genetic Testing
- An integral part of this segment, Orasure offers comprehensive services to support genetic testing initiatives. This includes training, consulting, and clinical trial support, ensuring that healthcare providers and researchers can effectively implement genetic testing in their practices.
Summary
Orasure Technologies Inc. delivers an extensive range of innovative products and services aimed at improving the quality and accessibility of infectious disease diagnostics and genomic analysis. With a focus on rapid testing, effective sample collection, and meticulous genomic research support, Orasure remains a key player in advancing healthcare technologies for better patient outcomes. Their products are strategically developed for use in clinical settings, research laboratories, and various healthcare facilities, ensuring they meet the evolving needs of the healthcare community.